Nucleotide

Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA

Retrieved on: 
Thursday, May 2, 2024
Biotechnology, Technology, Health, General Health, Pharmaceutical, Other Science, Other Technology, Medical Devices, Research, Genetics, Science, Safety, AKBA, EVP, RNA, Hynes Convention Center, DNA, ACS, Therapy, Booth, Nucleotide, Multimedia, AKB, Fine chemical

This new synthesis column offers drastically reduced changeover time between batches while maintaining user safety and product quality.

Key Points: 
  • This new synthesis column offers drastically reduced changeover time between batches while maintaining user safety and product quality.
  • View the full release here: https://www.businesswire.com/news/home/20240502639431/en/
    Concept image of the THESYS™ ACS ERGO synthesis column.
  • (Photo: Business Wire)
    Following the success of AKB’s DAC ERGO™, a liquid chromatography column, the company has continued advancing column technology with the THESYS™ ACS ERGO.
  • The THESYS ACS ERGO is designed for oligonucleotide synthesis and includes an operator-friendly design to facilitate a smooth and safe changeover between runs.

Introducing BODYHEALTH PERFECT AMINO™ with Nucleic Acid Building Blocks

Retrieved on: 
Friday, April 19, 2024
Collagen, Dicarboxylic acid, Cell, Health, Wellness, RNA, DNA, Tablet, Food, LOS, Essential amino acid, Meat, Nut, Nucleotide, Dietary supplement

LOS ANGELES, April 19, 2024 /PRNewswire/ -- BODYHEALTH® has announced its latest scientific breakthrough in supplement formulas: The newly enhanced PerfectAmino (a proprietary Essential Amino Acid blend), the brand's flagship product, has added Nucleic Acid Building Blocks to their tablet formula.

Key Points: 
  • Leading Health & Wellness brand introduces the addition of Nucleic Acid Building Blocks to their PerfectAmino tablets.
  • LOS ANGELES, April 19, 2024 /PRNewswire/ -- BODYHEALTH® has announced its latest scientific breakthrough in supplement formulas: The newly enhanced PerfectAmino (a proprietary Essential Amino Acid blend), the brand's flagship product, has added Nucleic Acid Building Blocks to their tablet formula.
  • Nucleic Acid Building Blocks (Nucleotides and Nucleosides) are the building blocks of DNA and RNA, the genetic codes that determine exactly how these amino acids are used in our bodies.
  • While most people know that protein is essential for optimum health, they assume they're getting enough from the food they eat.

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Genomics, Computational biology, Growth, Prevalence, Consumables, Intelligence, DSM-IV codes, Workflow, NGS, DNA, Cancer, Medicine, Nucleotide, Agilent Technologies, Investment, QIAGEN, Safety, Sanger sequencing, Disorder, Table, Vaccine

DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.

Key Points: 
  • DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.
  • However, the DNA sequencing market faces hurdles, including technical constraints, high costs, and the complexity of data interpretation, which impede broader adoption.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the DNA Sequencing Market.
  • "Dive into the DNA Sequencing Market Landscape: Explore 196 Pages of Insights, 562 Tables, and 24 Figures"

DNA Sequencing Market Projected to Reach $210.34 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, March 22, 2024
Genomics, Computational biology, Growth, Prevalence, Consumables, Intelligence, DSM-IV codes, Workflow, NGS, DNA, Cancer, Medicine, Nucleotide, Agilent Technologies, Investment, QIAGEN, Safety, Sanger sequencing, Disorder, Table, Vaccine

DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.

Key Points: 
  • DNA sequencing, a pivotal laboratory process that determines the order of nucleotides in DNA, has become crucial in diagnosing and treating diseases, medical research, and forensic studies.
  • However, the DNA sequencing market faces hurdles, including technical constraints, high costs, and the complexity of data interpretation, which impede broader adoption.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the DNA Sequencing Market.
  • "Dive into the DNA Sequencing Market Landscape: Explore 196 Pages of Insights, 562 Tables, and 24 Figures"

Bloomage receives highest honors from the All-China Women’s Federation

Retrieved on: 
Friday, March 8, 2024
International, Woman, Dicarboxylic acid, Education, Female, Nucleotide, Health, Hyaluronic acid, Creativity, Happiness, Protein, Science, Workforce

Bloomage has received the highest recognition from the All-China Women’s Federation for its trailblazing progress in these fields.

Key Points: 
  • Bloomage has received the highest recognition from the All-China Women’s Federation for its trailblazing progress in these fields.
  • “I am thrilled and honored for Bloomage to receive this prestigious award from the All-China Women’s Federation,” noted Bloomage Chairperson and CEO Zhao Yan.
  • Under Zhao Yan’s leadership, Bloomage is now the leading producer of hyaluronic acid, a key ingredient in many personal care and health products.
  • Bloomage has received these honors from the All-China Women’s Federation from its demonstrated robust commitment to promoting women in the workforce and taking actions to effectively advance gender equality which can drive stronger business outcomes.

Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Retrieved on: 
Wednesday, February 28, 2024
Therapy, Alnylam Pharmaceuticals, Senior, Enzyme, (glutamate—ammonia-ligase) adenylyltransferase, Doctor of Philosophy, Gene editing, Biotechnology, Roche, Pharmaceutical manufacturing, SAB, Telephone, McGill University, Phosphorylation, Research and development, Growth, DNA, ECO, RNA, Medication, Food, Nucleotide, Element, Administration, Exocrine pancreatic insufficiency, Central Waqf Council, Protein, Net, Small RNA, MBBS, RNA interference, Masad Damha, Video game

REDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023, and provided a business update.

Key Points: 
  • Including enzyme sales related to PAXLOVID™, total revenues were $26.6 million in fourth quarter 2023 compared to $30.4 million in fourth quarter 2022.
  • Including enzyme sales related to PAXLOVID™, product revenues were $18.1 million in fourth quarter 2023 compared to $23.3 million in fourth quarter 2022.
  • Product gross margin, excluding enzyme sales related to PAXLOVID™, was 71% for fourth quarter 2023 compared to 44% in fourth quarter 2022.
  • Including enzyme sales related to PAXLOVID™, product gross margin for fourth quarter 2023 was 84% compared to 64% in fourth quarter 2022.

Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging

Retrieved on: 
Friday, February 23, 2024
Methylation, Dysbiosis, Culture, Penn Center, Health, Bacteria, University, Subtypes of HIV, Life Length, Wistar Institute, Bangladesh Technical Education Board, Ileum, Infection, NIH, AIDS, Glass, Metabolomics, Nucleotide, DSM-IV codes, Biomedical Research, HIV/AIDS research, Wistar, University of Pittsburgh, DNA, Immune system, National Institutes of Health, Leiden University Medical Center, Weill Cornell Medicine, Hannum, Research, Inflammation, Blood, Ageing, Cancer, Cell biology, Microbiome, Rush University, HIV, DNA methylation, Vaccine

Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.

Key Points: 
  • Dr. Abdel-Mohsen investigates what drives this rapid aging and how to create ways to slow down biological aging and improve health.
  • A prime suspect in this aging puzzle is the gut microbiome and its potential leakage into the bloodstream.
  • The Abdel-Mohsen lab investigates how gut leakage can impact the immune system and lead to chronic inflammation, which may accelerate aging.
  • Their analysis revealed a significant connection between disrupted gut microbiomes, increased intestinal permeability (leaky gut), and faster biological aging.

Pyramid Labs Appoints Dirk Lange as CEO and Announces a Doubling of Commercial Fill-Finish Capacity

Retrieved on: 
Wednesday, March 6, 2024
Other Manufacturing, Professional Services, Manufacturing, Biotechnology, Health, Pharmaceutical, Retail, Asset Management, Supply Chain Management, Multimedia, Growth, Nucleotide, CDMO, Peptide, Pyramid, Protein, Knowledge, Audax, Management

View the full release here: https://www.businesswire.com/news/home/20240306544414/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240306544414/en/
    “I am excited to lead Pyramid during this pivotal time in the Company’s growth trajectory and as the company is doubling its commercial fill-finish capacity,” noted Dirk Lange.
  • Lange most recently led MilliporeSigma’s Life Science Services business and previously was the CEO of KBI Biopharma and Selexis.
  • He joins Pyramid at a point of accelerated growth, as the company is doubling its commercial fill-finish capacity.
  • “We are very pleased to welcome Dirk to the Pyramid team as we continue in our transformative growth phase,” commented Medhat Gorgy.

Oligonucleotide Synthesis Market to Exceed 9.9 billion by 2035 Say, Roots Analysis

Retrieved on: 
Wednesday, January 10, 2024
Neurological disorder, Centre for Process Innovation, University of Manchester, Overalls, Oligonucleotide, Intrinsic termination, DNA, Nucleotide, API, DSM-IV codes, MicroRNA, University, Novartis, Small RNA, Genetic testing, COVID-19, EUR, Therapy, FDF, AstraZeneca, Fine chemical

LONDON, Jan. 10, 2024 /PRNewswire/ -- The global oligonucleotide synthesis market is anticipated to be worth USD 3.5 billion in 2023, and it is expected to reach 9.9 billion by 2035. It is estimated to grow at a compounded annual growth rate (CAGR) of 16.1% during the forecast period (2023-2035).

Key Points: 
  • The oligonucleotide synthesis market faces several challenges, including the complexity of synthesis procedures, purification difficulties, gaps in analytical expertise, cost intensiveness, and regulatory constraints.
  • The growth factors for the oligonucleotide synthesis market include the expanding applications of oligonucleotides in genetic testing, diagnostics, and therapeutics.
  • Recent Developments in Oligonucleotide Synthesis Market:
    Several recent developments have taken place in the field of oligonucleotide synthesis.
  • FDF operation will dominate the oligonucleotide synthesis market during the forecast period and is anticipated to capture 53% of the market share in 2023.

Oligonucleotide Synthesis Market to Exceed 9.9 billion by 2035 Say, Roots Analysis

Retrieved on: 
Wednesday, January 10, 2024
Neurological disorder, Centre for Process Innovation, University of Manchester, Overalls, Oligonucleotide, Intrinsic termination, DNA, Nucleotide, API, DSM-IV codes, MicroRNA, University, Novartis, Small RNA, Genetic testing, De novo synthesis, COVID-19, EUR, Therapy, FDF, AstraZeneca, Fine chemical

LONDON, Jan. 10, 2024 /PRNewswire/ -- The global oligonucleotide synthesis market is anticipated to be worth USD 3.5 billion in 2023, and it is expected to reach 9.9 billion by 2035. It is estimated to grow at a compounded annual growth rate (CAGR) of 16.1% during the forecast period (2023-2035).

Key Points: 
  • The oligonucleotide synthesis market faces several challenges, including the complexity of synthesis procedures, purification difficulties, gaps in analytical expertise, cost intensiveness, and regulatory constraints.
  • The growth factors for the oligonucleotide synthesis market include the expanding applications of oligonucleotides in genetic testing, diagnostics, and therapeutics.
  • Recent Developments in Oligonucleotide Synthesis Market:
    Several recent developments have taken place in the field of oligonucleotide synthesis.
  • FDF operation will dominate the oligonucleotide synthesis market during the forecast period and is anticipated to capture 53% of the market share in 2023.